The personalized cancer vaccine market is gaining rapid momentum, driven by biotech advancements and rising demand for targeted immunotherapies. The new 2025 report analyzes key players like BioNTech, ...

Manufacture for the phase 2 trial, which could begin in a few ... to finalise the sequence for the SARS-CoV-2 vaccine and Moderna then began the clinical manufacturing process.

A phase 3 trial with mRNA-4157 for melanoma patients in ... berserk when they notice a free-floating mRNA strand. This is why ...

Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we ...

A specially-designed van is visiting rural parts of Cornwall to make it easier for people in "underserved and remote" areas to take part in clinical research. The Mobile Research Unit (MRU) is part of ...

The Pfizer and the Moderna vaccines are the first vaccines using messenger RNA technology ever cleared for human use outside of clinical trials. It is different from more traditional vaccines ...

The approval expands the indication for Amvuttra, which now becomes the first and only therapeutic approved by the FDA for ...

Moderna (MRNA) announced that the Medicines ... The approval is based on data from the Phase 3 clinical trial ConquerRSV, a randomized, placebo-controlled, observer-blind, case-driven clinical ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

It will also serve as the focal point of a clinical trials hub for Moderna, and a collaboration with the UK health services on R&D. The initial thrust of the new facility will be production of ...

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

Many trials exclude certain groups, and do so deliberately—children, for example, or people with physical or learning ...